<code id='63662A148A'></code><style id='63662A148A'></style>
    • <acronym id='63662A148A'></acronym>
      <center id='63662A148A'><center id='63662A148A'><tfoot id='63662A148A'></tfoot></center><abbr id='63662A148A'><dir id='63662A148A'><tfoot id='63662A148A'></tfoot><noframes id='63662A148A'>

    • <optgroup id='63662A148A'><strike id='63662A148A'><sup id='63662A148A'></sup></strike><code id='63662A148A'></code></optgroup>
        1. <b id='63662A148A'><label id='63662A148A'><select id='63662A148A'><dt id='63662A148A'><span id='63662A148A'></span></dt></select></label></b><u id='63662A148A'></u>
          <i id='63662A148A'><strike id='63662A148A'><tt id='63662A148A'><pre id='63662A148A'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:11992
          A close up photograph of an IV drop in a Portland hospital – politics and policy coverage from STAT
          A patient receives an IV drip at a hospital in Portland, Ore. Jenny Kane/AP

          WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          GOP presidential candidates start declaring their loyalty
          GOP presidential candidates start declaring their loyalty

          2:38FormerPresidentDonaldTrumplooksonduringthepro-ampriortotheLIVGolfInvitational-Bedminster,atTrump

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Readout Newsletter: Bristol, Sangamo, Gilead, and more

          EricRisberg/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsl